589 results on '"Block, Timothy M."'
Search Results
52. Molecular viral oncology of hepatocellular carcinoma
53. Chronic hepatitis B: What should be the goal for new therapies?
54. Overview of Hepatitis Viruses and Cancer
55. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays
56. Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen
57. Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection
58. Clinical Implications of the Molecular Biology of Hepatitis B Virus
59. Glucosidase Inhibition Enhances Presentation of De–N-Glycosylated Hepatitis B Virus Epitopes by Major Histocompatibility Complex Class I In Vitro and in Woodchucks
60. Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Dengue Virus: 178
61. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
62. Assays for glucosidase inhibitors with potential antiviral activities: secreted alkaline phosphatase as a surrogate marker
63. Detection of Mutated K-ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps
64. Removal of High-Molecular-Weight DNA by Carboxylated Magnetic Beads Enhances the Detection of Mutated K-ras DNA in Urine
65. A Novel and Selective Inhibitor of Hepatitis B Virus Surface Antigen Secretion: 22
66. Glucosidase/protein folding inhibitors as possible mutation-proof, anti-hepatitis B & C agents
67. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin (antivirals/glycosylation)
68. Human Urine Contains Small, 150 to 250 Nucleotide-Sized, Soluble DNA Derived from the Circulation and May Be Useful in the Detection of Colorectal Cancer
69. Transrenal DNA as a Diagnostic Tool: Important Technical Notes
70. Synthetic and natural glycolipids induce 2-5-OA synthetase transcripts and have direct antiviral activity against hepatitis B virus (HBV): 9
71. Emerging Therapies in the Treatment of Hepatitis B Virus
72. Inhibition of Host ER Glucosidase Activity Prevents Golgi Processing of Virion-Associated Bovine Viral Diarrhea Virus E2 Glycoproteins and Reduces Infectivity of Secreted Virions
73. A Glycoform of Immunoglobulin G (IgG) as an Early Biomarker of Exposure to Nonhuman Substances
74. Correction: Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma
75. Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B
76. Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma
77. Do hepatitis B virus surface antigens have any role in viral carcinogenesis?
78. Disease Pathways and Mechanisms of Potential Drug Targets
79. Identification of a Novel 0.7-kb Polyadenylated Transcript in the LAT Promoter Region of HSV-1 That Is Strain Specific and May Contribute to Virulence
80. Glyco- and peptidomimetics from three-component Joullie-Ugi coupling show antiviral activity
81. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly
82. Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma
83. Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA
84. Ester Prodrugs of IHVR-19029 with Enhanced Oral Exposure and Prevention of Gastrointestinal Glucosidase Interaction
85. A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein
86. Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis
87. Geneticin stabilizes the open conformation of the 5′ region of hepatitis C virus RNA and inhibits viral replication
88. Design and synthesis of N-alkyldeoxynojirimycin derivatives with improved metabolic stability as inhibitors of BVDV and Tacaribe virus
89. N-Alkyldeoxynojirimycin derivatives with novel terminal tertiary amide substitution for treatment of bovine viral diarrhea virus (BVDV), Dengue, and Tacaribe virus infections
90. Abstract 4934: Detection of HBV-host junction DNA sequences in urine of patients with hepatocellular carcinoma
91. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma
92. Geneticin Stabilizes the Open Conformation of the 5′ Region of Hepatitis C Virus RNA and Inhibits Viral Replication
93. The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in “Site”?
94. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion
95. Chronic hepatitis B: A wave of new therapies on the horizon
96. Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues
97. STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus
98. Inhibition of Endoplasmic Reticulum-Resident Glucosidases Impairs Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Spike Protein-Mediated Entry by Altering the Glycan Processing of Angiotensin I-Converting Enzyme 2
99. Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis
100. Human Immunodeficiency Virus-related Microbial Translocation and Progression of Hepatitis C: HIV, HCV, Microbial Translocation and Liver Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.